For the first time since 2010, the American Cancer Society (ACS) has updated its prostate cancer screening guidelines, now recommending PSA (prostate-specific antigen) testing every two years for average-risk men ages 50 to 69 and annual screening starting at age 45 for Black men and men with a strong family history of the disease. In the U.S., prostate cancer is the second-leading cause of cancer death among men, and in 2026, an estimated 333,830 men will be diagnosed with the disease, with more than 36,000 expected to die from it.
“The prior guidelines didn’t directly recommend regular screening because there was uncertainty about the balance of benefits and harms. It advised that most men engage in shared decision-making about testing with their healthcare provider, with consideration of their values and preferences in the presence of uncertainty,” says Robert Smith, PhD , Senior Vice President of Early Cancer Detection Science for the American Cancer Society and senior author of the report.…